In silico modelling approaches are useful since they can minimise experimental costs and once set up can be used to replace animal testing for drugs. As such modelling techniques need to be developed to reduce dependence on animals for validation of pharmacological efficacy. The work within this thesis shows that computational methods can be used to model biological and medical problems effectively. The main aim of this thesis was to investigate Cytochrome P450 enzymes and their effect on drug metabolism through the use of the Hepatic Reductase Null(HRN) mouse. This was done through using a number of computational models and compared with drug data provided by CXR Biosciences. These models ranged from solely ODE (for comparison to experimental data) to multiscale cellular automata and spatial models when analysing the dynamics on the tumour and cellular level. Once these models were developed the parametric sensitivity was derived in order to see whether there were any needless parameters so that the models were streamlined and to test the model`s robustness against error. The novel three-compartment model was developed in order to explain dynamics within the Hepatic Reductase Null mouse was able to explain much of the behaviour in the supplied data. As well as this it was discovered that the transgenic mouse showed reduced speed in metabolism for many of the drugs analysed which meant that different models were necessary.The cellular automaton program presented is applicable to other areas other than the one stated in Chapter 5. For example any area that deals with interactions between tissue media and drugs as in toxicology and drug studies. The cell cycle inside the code deals with tumour cells but this code can be re-parameterised to concentrate on other types of cell including normal cells, hepatic tissue etc. The inclusion of spatial e ects to the deterministic models like the Cytochrome P450 cycle allows for greater realism in predictions of drug passage through the body or across certain tissue media. Due to this it is useful to include both deterministic and spatial modelling with a multiscale approach in models for drug metabolism.
|Date of Award||2011|
|Sponsors||Engineering and Physical Sciences Research Council & CXR Biosciences Ltd|
|Supervisor||Mark Chaplain (Supervisor)|